ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer

Chambers, Suzanne K, Ferguson, Megan, Gardiner, R. A., Nicol, David, Gordon, Louisa, Occhipinti, Stefano and Aitken, Joanne (2008) ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer. BMC Cancer, 8 207: 1-7. doi:10.1186/1471-2407-8-207


Author Chambers, Suzanne K
Ferguson, Megan
Gardiner, R. A.
Nicol, David
Gordon, Louisa
Occhipinti, Stefano
Aitken, Joanne
Title ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer
Journal name BMC Cancer   Check publisher's open access policy
ISSN 1471-2407
Publication date 2008-01-01
Sub-type Article (original research)
DOI 10.1186/1471-2407-8-207
Open Access Status DOI
Volume 8
Issue 207
Start page 1
End page 7
Total pages 7
Editor Godlee, Fiona
Norton, Melissa Dr.
Place of publication United Kingdom
Publisher BioMed Central Ltd.
Language eng
Subject C1
920102 Cancer and Related Disorders
920504 Men's Health
111712 Health Promotion
Formatted abstract
Background: Prostate cancer is the most common male cancer in the Western world but is highly heterogeneous in disease progression and outcomes. Consequently, the most substantial morbidity may actually arise from the adverse psychosocial impact of distress in decision-making and long term quality of life effects such as impotence. This paper presents the design of a randomised controlled trial of a decision support/psychosocial intervention for men newly diagnosed with localised prostate cancer.

Methods/Design: 350 men per condition (700 men in total) have been recruited after diagnosis and before treatment through urology private practices and hospital outpatient clinics and randomised to 1) a tele-based nurse delivered five session decision support/psychosocial intervention or 2) a usual care control group. Two intervention sessions are delivered before treatment that address decision support, stress management and preparation for treatment. Three further sessions are provided three weeks, seven weeks and five months after treatment that focus on adjustment to cancer, problem solving and coping with treatment side effects. Participants are assessed at baseline (before treatment) and 2, 6, 12, 24 and 36 months post-treatment. Outcome measures include: cancer threat appraisal; decision-related distress and bother from treatment side effects; involvement in decision making; satisfaction with health care; heath care utilisation; use of health care resources; and a return to previous activities.

Discussion:
The study will provide recommendations about the efficacy of early decision support to facilitate adjustment after prostate cancer. As well the study will identify men diagnosed with localised prostate cancer at risk of poorer long term psychosocial adjustment.
Keyword Quality-of-life
psychological distress
intrusive thoughts
Carcinoma
health
scale
Predictors
uncertainty
prevalence
validation
Q-Index Code C1
Q-Index Status Confirmed Code

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 20 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 21 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 08 Apr 2009, 21:26:19 EST by Cathy Swart on behalf of School of Public Health